Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence. 2025

Brian M Ross
Division of Medical Sciences, NOSM University, Thunder Bay, ON, Canada.

Psychedelics, such as LSD and psilocybin, disrupt entrenched cognitive patterns by facilitating novel insights and new associations. This paper considers how AI can potentially mimic these psychedelic-induced cognitive disruptions to augment and enhance human creativity. Psychedelics likely enhance creativity by altering brain function, notably the activity of the Default Mode Network, which leads to changes in cognition. Psychologically, they may reduce latent inhibition, increase divergent thinking, and promote implicit learning. Similarly, AI systems can replicate these creative enhancements by introducing novel associations, reframing familiar information, and facilitating unconscious cognitive shifts. The risks associated with AI use are also compared to psychedelics, including dependency, ethical concerns, and homogenization of outputs due to bias. Integrating the cognitive mechanisms activated by psychedelics into AI design provides promising pathways for creativity enhancement. Carefully designed AI could act as a cognitive catalyst, fostering innovative thought processes and adaptive problem-solving while addressing identified ethical and practical concerns.

UI MeSH Term Description Entries

Related Publications

Brian M Ross
February 2019, Science (New York, N.Y.),
Brian M Ross
July 2025, American journal of veterinary research,
Brian M Ross
July 2017, Neuron,
Brian M Ross
January 2019, Frontiers in psychology,
Brian M Ross
January 2024, Annual review of psychology,
Brian M Ross
February 2025, Bulletin of the World Health Organization,
Brian M Ross
March 2022, Proceedings of the National Academy of Sciences of the United States of America,
Brian M Ross
January 2018, Progress in brain research,
Copied contents to your clipboard!